Smolen, JS, Aletaha, D. & McInnes, IB Rheumatoid arthritis. Lancet 3882023–2038 (2016).
Scott, DL, Wolfe, F. & Huizinga, TW Rheumatoid arthritis. Lancet 3761094–1108 (2010).
Garrod, A.E A treatise on rheumatism and rheumatoid arthritis (Griffin’s medical series, 1890).
Google Scholar
Shlobin, NA & Dahdaleh, NS Cervical spine manifestations of rheumatoid arthritis: a review. Neurosurgeon. Rev. 441957–1965 (2021).
Kim, HJ, Nemani, VM, Riew, KD & Brasington, R. Cervical spine disease in rheumatoid arthritis: incidence, manifestations and therapy. Current Rheumatoid. Rep. 179 (2015).
Chattopadhyay, A., Samanta, J., Jindal, A. & Jain, S. Neck pain in rheumatoid arthritis: a look beyond cervical spine involvement. Rheumatology (Oxford) 60471 (2021).
Carotti, M., Salaffi, F., Di Carlo, M., Sessa, F. & Giovagnoni, A. Magnetic resonance imaging of the craniovertebral junction in early rheumatoid arthritis. Skeleton. Radiol. 48553–561 (2019).
Drosos, AA, Pelechas, E. & Voulgari, PV Radiological findings of the cervical spine in rheumatoid arthritis: what a rheumatologist should know. Current Rheumatoid. Rep. 2219 (2020).
Kaito, T. et al. Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacological treatment paradigm. Mod. Rheumatoid. 27593–597 (2017).
Montemerani, M. et al. Involvement of the atlantoaxial joint in rheumatoid arthritis: rare or frequent? Klin. Rheumatoid. 13459–463 (1994).
Zhang, T. & Pope, J. Involvement of the cervical spine in rheumatoid arthritis over time: results from a meta-analysis. Arthritis Res. Over there. 17148 (2015).
Aletaha, D. et al. 2010 Rheumatoid Arthritis Classification Criteria: A Collaborative Initiative of the American College of Rheumatology/European League Against Rheumatism. Ann. Rheum. Dis. 691580–1588 (2010).
Duru, N. et al. EULAR evidence-based and consensus recommendations for the treatment of moderate to high dose glucocorticoid therapy in rheumatic diseases. Ann. Rheum. Dis. 721905–1913 (2013).
Peduzzi, P., Concato, J., Kemper, E., Holford, TR & Feinstein, AR A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 491373–1379 (1996).
Groenland, S., Schwartzbaum, J. A. & Finkle, W. D. Problems due to small sample sizes and sparse data in conditional logistic regression analysis. Ben. J. Epidemiol. 1(151), 531-539 (2000).
Joaquim, A. F., Ghizoni, E., Tedeschi, H., Appenzeller, S. & Riew, K. D. Radiological evaluation of cervical spine involvement in rheumatoid arthritis. Neurosurgeon. Focus 38E4 (2015).
Castro, S. et al. Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. Klin. Execution Rheumatoid. 12369–374 (1994).
Baek, IW, Joo, YB, Park, KS & Kim, KJ Risk factors for cervical spine instability in patients with rheumatoid arthritis. Klin. Rheumatoid. 40547–555 (2021).
Kotecki, M., Gasik, R., Głuszko, P. & Sudoł-Szopińska, I. Radiological evaluation of cervical spine involvement in rheumatoid arthritis: a cross-sectional retrospective study. J. Clin. Med. 104587 (2021).
Hyrich, KL, Watson, KD, Silman, AJ, Symmons, DP, British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha therapy in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 451558-1565 (2006).
Kvien, TK, Uhlig, T., Ødegård, S. & Heiberg, M. S. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann. NY Acad. Science 1069212–222 (2006).
Mancarella, L. et al. Good clinical response, remission and predictors of remission in patients with rheumatoid arthritis treated with tumor necrosis factor alpha blockers: the GISEA study. J. Rheumatol. 341670–1673 (2007).
Kocijan, R., Harre, U. & Schett, G. ACPA and bone loss in rheumatoid arthritis. Current Rheumatoid. Rep. 15366 (2013).
Katchamart, W., Koolvisoot, A., Aromdee, E., Chiowchanwesawakit, P. & Muengchan, C. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatoid. Int. 351693–1699 (2015).
Symmonen, D. et al. Patients with stable, long-standing rheumatoid arthritis continue to deteriorate despite increased treatment with traditional disease-modifying anti-rheumatic drugs – Results from the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) 45558-565 (2006).
Turesson, C. Extra-articular rheumatoid arthritis. Current opinion. Rheumatoid. 25360–366 (2013).
Conforti, A. et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmune. Rev. 20102735 (2021).
Bruno, F. et al. New developments in MRI diagnosis of degenerative osteoarthropathy of the peripheral joints. Radiol. Of. 1241121–1127 (2019).
Østergaard, M. & Boesen, M. Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography. Radiol. Of. 1241128–1141 (2019).
Bariel, A. et al. Computed tomography and MR imaging in rheumatoid arthritis. Radiol. Klin. North Am. 55997–1007 (2017).
Bruno, F. et al. MR imaging of the upper limb: pitfalls, tricks and tips. Radiol. Klin. North Am. 571051–1062 (2019).
Buch, MH Defining refractory rheumatoid arthritis. Ann. Rheum. Dis. 77966–969 (2018).
Shop, MJ et al. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease-modifying antirheumatic drugs. J. Rheumatol. 36273–278 (2009).
Kaito, T. et al. Effect of biological agents on cervical spine lesions in rheumatoid arthritis. Spine (Phila Pa 1976) 371742–1746 (2012).
Kanayama, Y. (1999). et al. Radiographic progression of cervical lesions in patients with rheumatoid arthritis treated with infliximab. Mod. Rheumatoid. 20273–279 (2010).
Wasserman, BR, Moskovich, R. & Razi, AE Rheumatoid arthritis of the cervical spine – Clinical considerations. Taurus. NYU Hospital. Jt. Dis. 69136–148 (2011).
Cipriani, P. et al. Biological therapies and infections in daily practice of three Italian rheumatology units: a prospective, observational study. Klin. Rheumatoid. 36251–260 (2017).
Giacomelli, R. et al. Guidelines for biomarkers in autoimmune rheumatic diseases: evidence-based analysis. Autoimmune. Rev. 1893–106 (2019).
Giacomelli, R. et al. International consensus: what more can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjögren’s syndrome)?: The unmet needs and the clinical gray zone in the treatment of autoimmune diseases. Autoimmune. Rev. 16911–924 (2017).
Giacomelli, R. et al. The growing role of precision medicine for the treatment of autoimmune diseases; Results of a systematic review of literature and expert consensus. Autoimmune. Rev. 20102738 (2021).
Leave a Reply